SCHEMBL7932104

SCHEMBL7932104

CN(C)C1CC(c2ccc(Cl)c(Cl)c2)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 11/20 1.00
SLC6A3 Q01959 11/20 1.00
SLC6A4 P31645 10/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932101 1.00 SLC6A2 (1.00) SLC6A2SLC6A3SLC6A4
Fumaric Acid SCHEMBL7932100 0.89 SLC6A4 (1.00) SLC6A2SLC6A3SLC6A4
SCHEMBL11127495 0.87 SLC6A2 (0.77) SLC6A2SLC6A3SLC6A4
SCHEMBL6944959 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL11133547 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL8253409 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL10995616 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL11133286 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL9843400 0.87 SLC6A2 (0.76) SLC6A2SLC6A3SLC6A4
SCHEMBL11128129 0.83 SLC6A2 (0.71) SLC6A2SLC6A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6268535-B1 REACTING BENZENE SUBSTITUTED UNSATURATED CARBOXYLIC ACID IN PRESENCE OF FRIEDEL-CRAFT CATALYST WITH BENZENE COMPOUND TO FORM 3-ARYL-3-PHENYL-1-PROPANOIC ACID REACTING TO FORM 3-ARYL INDAN; REDUCING, REACTING WITH AMINE TO FORM 3-ARYLINDANAMINE PHARM-ECO LABORATORIES, INC. 2001-07-31 US disclosed
EP-1044184-A1 SYNTHESIS OF 3-ARYL-1-INDANAMINES Pharm-Eco Laboratoires, Incorporated (US) 2000-10-18 EP disclosed
US-6011070-A TREATING AN INDIVIDUAL WHO ABUSES COCAINE, AN INDIVIDUAL WITH PARKINSON'S DISEASE OR AN INDIVIDUAL WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER ALLELIX-PHARM-ECO L.P. (US) 2000-01-04 US disclosed
WO-1999035119-A1 SYNTHESIS OF 3-ARYL-1-INDANAMINES PHARM-ECO LABORATORIES, INC. (US) 1999-07-15 WO disclosed